Standalone revenue decline was limited to 16.2% QoQ at | 239 crore vs. >50% M&HCV; volume decline domestically; largely aided by exports EBITDA margins were down ~170 bps QoQ to 18.1%, tracking negative operating leverage; gross margins rose ~100 bps sequentially Consequent PAT declined ~21% sequentially to | 24 crore...